Lifecore Biomedical, Inc. De (LFCR) Shares Outstanding (Weighted Average) (2010 - 2025)

Lifecore Biomedical's Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $34.8 million for Q2 2025.

• In Q2 2025, Shares Outstanding (Weighted Average) rose 14.26% year-over-year to $34.8 million; the TTM figure through May 2025 stood at $34.8 million (up 14.26% YoY), while the FY2025 annual figure was $34.8 million, up 14.26% from the prior year.
• Shares Outstanding (Weighted Average) was $34.8 million for Q2 2025 at Lifecore Biomedical, down from $37.0 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $37.0 million in Q1 2025 to a low of $29.3 million in Q1 2021.
• Historically, Shares Outstanding (Weighted Average) has averaged $30.8 million across 5 years, with a median of $30.1 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Weighted Average) climbed 0.38% in 2021, then gained 21.58% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $29.5 million in 2021, then rose by 0.55% to $29.6 million in 2022, then grew by 2.69% to $30.4 million in 2023, then rose by 12.91% to $34.4 million in 2024, then grew by 1.33% to $34.8 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $34.8 million (Q2 2025), $37.0 million (Q1 2025), and $34.4 million (Q4 2024), per Business Quant data.